Share on StockTwits

Celladon Corp (NASDAQ:CLDN) issued its quarterly earnings data on Thursday. The company reported ($0.38) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.38), Analyst RN reports.

Shares of Celladon Corp (NASDAQ:CLDN) traded down 2.75% during mid-day trading on Thursday, hitting $10.25. The stock had a trading volume of 48,552 shares. Celladon Corp has a 52 week low of $7.45 and a 52 week high of $17.16. The stock’s 50-day moving average is $13.59 and its 200-day moving average is $11.34. The company’s market cap is $189.6 million.

Celladon Corporation (NASDAQ:CLDN) is a clinical-stage biotechnology company.

Receive News & Ratings for Celladon Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celladon Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.